BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31098856)

  • 1. Cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.
    Rim SH; Allaire BT; Ekwueme DU; Miller JW; Subramanian S; Hall IJ; Hoerger TJ
    Cancer Causes Control; 2019 Aug; 30(8):819-826. PubMed ID: 31098856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.
    Allaire BT; Ekweme D; Hoerger TJ; DeGroff A; Rim SH; Subramanian S; Miller JW
    Cancer Causes Control; 2019 Sep; 30(9):923-929. PubMed ID: 31297693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of delivery structure on costs, screening and health promotional services in state level National Breast and Cervical Cancer Early Detection Programs.
    Trogdon JG; Ekwueme DU; Subramanian S; Miller JW; Wong FL
    Cancer Causes Control; 2019 Aug; 30(8):813-818. PubMed ID: 31187351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
    Geuzinge HA; Obdeijn IM; Rutgers EJT; Saadatmand S; Mann RM; Oosterwijk JC; Tollenaar RAEM; de Roy van Zuidewijn DBW; Lobbes MBI; van 't Riet M; Hooning MJ; Ausems MGEM; Loo CE; Wesseling J; Luiten EJT; Zonderland HM; Verhoef C; Heijnsdijk EAM; Tilanus-Linthorst MMA; de Koning HJ;
    JAMA Oncol; 2020 Sep; 6(9):1381-1389. PubMed ID: 32729887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the impact of increasing cervical cancer screening in the National Breast and Cervical Cancer Early Detection Program among low-income women in the USA.
    Pollack LM; Ekwueme DU; Hung MC; Miller JW; Chang SH
    Cancer Causes Control; 2020 Jul; 31(7):691-702. PubMed ID: 32436037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of adding tomosynthesis to mammography-based breast cancer screening: an economic analysis.
    Cressman S; Mar C; Sam J; Kan L; Lohrisch C; Spinelli JJ
    CMAJ Open; 2021; 9(2):E443-E450. PubMed ID: 33888549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of risk-based breast cancer screening programme, China.
    Sun L; Legood R; Sadique Z; Dos-Santos-Silva I; Yang L
    Bull World Health Organ; 2018 Aug; 96(8):568-577. PubMed ID: 30104797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the National Breast and Cervical Cancer Early Detection Program on cervical cancer mortality among uninsured low-income women in the U.S., 1991-2007.
    Ekwueme DU; Uzunangelov VJ; Hoerger TJ; Miller JW; Saraiya M; Benard VB; Hall IJ; Royalty J; Li C; Myers ER
    Am J Prev Med; 2014 Sep; 47(3):300-8. PubMed ID: 25015564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis.
    Gray E; Donten A; Karssemeijer N; van Gils C; Evans DG; Astley S; Payne K
    Value Health; 2017 Sep; 20(8):1100-1109. PubMed ID: 28964442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
    Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
    Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis.
    Arrospide A; Rue M; van Ravesteyn NT; Comas M; Soto-Gordoa M; Sarriugarte G; Mar J
    BMC Cancer; 2016 Jun; 16():344. PubMed ID: 27251556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality.
    Hoerger TJ; Ekwueme DU; Miller JW; Uzunangelov V; Hall IJ; Segel J; Royalty J; Gardner JG; Smith JL; Li C
    Am J Prev Med; 2011 Apr; 40(4):397-404. PubMed ID: 21406272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
    Mohan G; Chattopadhyay S
    JAMA Oncol; 2020 Sep; 6(9):1434-1444. PubMed ID: 32556187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of services provided by the National Breast and Cervical Cancer Early Detection Program.
    Ekwueme DU; Subramanian S; Trogdon JG; Miller JW; Royalty JE; Li C; Guy GP; Crouse W; Thompson H; Gardner JG
    Cancer; 2014 Aug; 120 Suppl 16(Suppl 16):2604-11. PubMed ID: 25099904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of early detection of breast cancer in Catalonia (Spain).
    Carles M; Vilaprinyo E; Cots F; Gregori A; Pla R; Román R; Sala M; Macià F; Castells X; Rue M
    BMC Cancer; 2011 May; 11():192. PubMed ID: 21605383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total cost-effectiveness of mammography screening strategies.
    Mittmann N; Stout NK; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Yaffe MJ
    Health Rep; 2015 Dec; 26(12):16-25. PubMed ID: 26676235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economics of public health programs for underserved populations: a review of economic analysis of the National Breast and Cervical Cancer Early Detection Program.
    Khushalani JS; Trogdon JG; Ekwueme DU; Yabroff KR
    Cancer Causes Control; 2019 Dec; 30(12):1351-1363. PubMed ID: 31598825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost-effectiveness of an organized breast cancer screening program in Southern Brazil].
    Ribeiro RA; Caleffi M; Polanczyk CA
    Cad Saude Publica; 2013 Nov; 29 Suppl 1():S131-45. PubMed ID: 25402242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai].
    Wu F; Mo M; Qin XX; Fang H; Zhao GM; Liu GY; Chen YY; Cao ZG; Yan YJ; Lyu LL; Xu WH; Shao ZM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Dec; 38(12):1665-1671. PubMed ID: 29294584
    [No Abstract]   [Full Text] [Related]  

  • 20. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.
    Schiller-Fruehwirth I; Jahn B; Einzinger P; Zauner G; Urach C; Siebert U
    Value Health; 2017 Sep; 20(8):1048-1057. PubMed ID: 28964436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.